Back

Critical illness expands a transcriptionally distinct hypometabolic CD8+ T effector program associated with respiratory failure and mortality

Nichols, C. M.; Mwizerwa, E. L.; Sim, C. Y.; Obeidalla, S. N.; Cephus, J.-Y.; Roe, C. E.; Irish, J. M.; Newcomb, D. C.; Kerchberger, V. E.; Bastarache, J. A.; Rathmell, J. C.; Ware, L. B.; Stier, M. T.

2026-06-01 immunology
10.64898/2026.05.28.728555 bioRxiv
Show abstract

Immune dysfunction is a major driver of morbidity and mortality in critical illness syndromes including sepsis. Specifically, CD8+ T cell dysfunction has been linked to organ failure and death. To characterize the immune substructure of circulating CD8+ T cells in critical illness at high dimension, we used single-cell RNA sequencing of peripheral blood CD8+ T cells from 38 critically ill patients and 9 healthy controls. We annotated seven CD8+ T cell clusters, which included a CD8+ effector subset, termed T effector state 2 (TEff-2), that was only present in critically ill patients and associated with more severe respiratory failure and higher mortality. TEff-2 showed effector activation and inflammatory stress conditioning yet had markedly reduced metabolic transcripts without canonical features of exhaustion. Trajectory analyses positioned TEff-2 as a terminal CD8+ T effector cell fate driven in part by DDIT4 and DUSP1, which negatively regulate mTOR and MAPK signaling, respectively. Interestingly, this transcriptional program was indistinguishable by classical protein cytometry methods. These results, including the mortality association, were validated in a larger (n=91) independent external cohort of critically ill patients with sepsis. In summary, TEff-2 represents a latent transcriptional program that delineates a clinically high-risk CD8+ T cell state in critical illness.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Immunology
71 papers in training set
Top 0.1%
10.2%
2
Immunity
58 papers in training set
Top 0.5%
9.9%
3
Nature Communications
4913 papers in training set
Top 19%
9.9%
4
Journal of Experimental Medicine
106 papers in training set
Top 0.4%
6.3%
5
Science
429 papers in training set
Top 6%
6.2%
6
Science Immunology
81 papers in training set
Top 0.3%
6.2%
7
Cell Reports Medicine
140 papers in training set
Top 0.8%
4.8%
50% of probability mass above
8
Cell Reports
1338 papers in training set
Top 10%
4.8%
9
Nature Medicine
117 papers in training set
Top 0.5%
4.8%
10
Nature
575 papers in training set
Top 6%
4.2%
11
Science Translational Medicine
111 papers in training set
Top 0.7%
3.9%
12
Cell
370 papers in training set
Top 7%
3.5%
13
eLife
5422 papers in training set
Top 33%
2.6%
14
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 28%
2.1%
15
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
16
Cell Metabolism
49 papers in training set
Top 1%
1.6%
17
Genome Medicine
154 papers in training set
Top 7%
0.9%
18
Science Advances
1098 papers in training set
Top 29%
0.8%
19
JCI Insight
241 papers in training set
Top 8%
0.7%
20
Cancer Discovery
61 papers in training set
Top 2%
0.7%
21
Circulation
66 papers in training set
Top 3%
0.6%
22
Nature Cancer
35 papers in training set
Top 2%
0.6%
23
iScience
1063 papers in training set
Top 38%
0.6%
24
Nature Microbiology
133 papers in training set
Top 5%
0.6%